Alps Advisors Inc Dbv Technologies S.A. Transaction History

Alps Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 25, 2018	SELL	$18.6 - $24.94 $216,615 - $290,451	-11,646 Reduced 17.38%	55,358 $1.36 Million
Q1 2018 May 01, 2018	BUY	$20.86 - $26.6 $242,935 - $309,783	11,646 Added 21.04%	67,004 $1.55 Million
Q4 2017 Feb 05, 2018	BUY	$20.9 - $49.36 $164,712 - $389,006	7,881 Added 16.6%	55,358 $1.36 Million
Q3 2017 Nov 03, 2017	BUY	$39.62 - $46.17 $1.88 Million - $2.19 Million	47,477	47,477 $2.02 Million

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $937M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.